Results 71 to 80 of about 136,511 (176)
Insight into high myopia and the macula
The incidence of myopia is constantly on the rise. Patients of high myopia and pathological myopia are young and can lose vision due to a number of degenerative changes occurring at the macula.
Atul Kumar +3 more
doaj +1 more source
Purpose: To introduce the application of intraoperative optical coherence tomography (iOCT) in pars plana vitrectomy (PPV) for various vitreoretinal diseases, and to report the 4-year assessment of feasibility and utility in Chinese population.
Jiwei Tao +7 more
doaj +1 more source
Abstract Purpose To evaluate the clinical features and treatment outcomes of bilateral myopic macular neovascularization (mMNV). Methods This single‐centre retrospective study included patients with bilateral high myopia who were newly diagnosed with unilateral mMNV (first eye) between January 2008 and July 2020.
Soo Hyun Lim +5 more
wiley +1 more source
Introduction To investigate changes in the vitreoretinal interface after anti-vascular endothelial growth factor (anti-VEGF) treatment in highly myopic eyes. Methods Eyes with myopic choroidal neovascularization (mCNV) treated with intravitreal injection
Mei-Chi Tsui +10 more
doaj +1 more source
Purpose: To report the anatomic and visual outcomes following macular buckling in patients affected by pathological myopia-associated foveoschisis (FS) and macular detachment with or without macular hole (MH).
Pradeep Susvar +3 more
doaj +1 more source
Frequency of retinal findings after 8 years in the Bifocal Lenses in Nearsighted Kids (BLINK) Study
Abstract Purpose The purpose of the study is to report the frequency of retinal findings in myopic children and determine the association with the amount of myopia or axial length. Design The BLINK study was a myopia control, multi‐centre randomised clinical trial following myopic children with multifocal soft contact lenses. Participants Children aged
Krystal L. Schulle +44 more
wiley +1 more source
Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)
ABSTRACT Background Intravitreal bevacizumab has been used off‐label to treat multiple ocular conditions for almost two decades. Reference bevacizumab, Avastin, was discontinued in Australia in 2021. A bevacizumab biosimilar, MVASI, was approved by the Therapeutic Goods Administration for the treatment of metastatic cancer in 2020.
Hanru Wang +8 more
wiley +1 more source
Can fundus features tell us something about 3D eye shape?
Abstract Purpose To determine whether imaging features derived from fundus photographs contain 3D eye shape information beyond that available from spherical equivalent refraction (SER). Methods We analysed 99 eyes of 68 normal adults in the UK Biobank. An ellipsoid was fitted to the entire volume of each posterior eye (vitreous chamber without the lens)
Fabian Yii +3 more
wiley +1 more source
Choroidal Perfusion Changes After Vitrectomy for Myopic Traction Maculopathy
The choroidal vasculature supplies the outer retina and is altered in many retinal diseases, including myopic traction maculopathy (MTM). Choroid health is typically assessed by measuring the choroidal thickness; however, this method has substantial limitations.
Miguel A, Quiroz-Reyes +3 more
openaire +2 more sources
The proposed artificial intelligence model, cross‐subject meta‐transfer learning, enables the automatic detection of vitreoretinal lymphoma (VRL) on optical coherence tomography images among 16 retinal diseases and conditions. This study provides an innovative solution to assist in the VRL diagnosis in real‐world clinical implementation, showing ...
Aidi Lin +23 more
wiley +1 more source

